Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Helminth-Secreted Ascarosides as a Treatment for Inflammatory Bowel Disease

FY 2016-17

Summary
Inflammatory bowel diseases (IBDs) are characterized by chronic inflammation of the digestive tract. While rarely fatal, IBDs such as Ulcerative Colitis and Crohn's Disease significantly decrease the quality of life of almost 250,000 Canadians. Although the causes of IBD are not well understood, hyperactive immune responses are known to contribute. To address this, current treatments involve broad-spectrum suppression of the immune system. While effective, these treatments leave patients vulnerable to infection. Thus, there is an urgent need to develop novel treatments for IBD.Recently there has been interest in using parasitic worms to treat IBD. Many worms suppress host immune responses by secreting a variety of compounds. While early data suggested that giving patients worm eggs could be used to treat IBD, more recent large-scale clinical trials have been inconclusive. Furthermore, worms are associated with other negative health effects, including the suppression of antiviral immunity. In light of the issues with using live worms to treat IBD, efforts have been made to isolate the anti-inflammatory effects of worm infections from the negative health effects. To this end, the worm-secreted molecule ascr#7 was investigated. Preliminary evidence in mice has suggested that ascr#7 could be used to prevent the onset of IBD without suppressing antiviral immunity. In this study, I aim to build on this preliminary evidence to evaluate ascr#7 as a potential treatment for IBD.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367330
Name
Sharon Andrew J
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Helminth-Secreted Ascarosides as a Treatment for Inflammatory Bowel Disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Inflammation; Co-Infection; Inflammatory Bowel Disease; Parasite; Virus
Abstract
Inflammatory bowel diseases (IBDs) are characterized by chronic inflammation of the digestive tract. While rarely fatal, IBDs such as Ulcerative Colitis and Crohn's Disease significantly decrease the quality of life of almost 250,000 Canadians. Although the causes of IBD are not well understood, hyperactive immune responses are known to contribute. To address this, current treatments involve broad-spectrum suppression of the immune system. While effective, these treatments leave patients vulnerable to infection. Thus, there is an urgent need to develop novel treatments for IBD.Recently there has been interest in using parasitic worms to treat IBD. Many worms suppress host immune responses by secreting a variety of compounds. While early data suggested that giving patients worm eggs could be used to treat IBD, more recent large-scale clinical trials have been inconclusive. Furthermore, worms are associated with other negative health effects, including the suppression of antiviral immunity. In light of the issues with using live worms to treat IBD, efforts have been made to isolate the anti-inflammatory effects of worm infections from the negative health effects. To this end, the worm-secreted molecule ascr#7 was investigated. Preliminary evidence in mice has suggested that ascr#7 could be used to prevent the onset of IBD without suppressing antiviral immunity. In this study, I aim to build on this preliminary evidence to evaluate ascr#7 as a potential treatment for IBD.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sharon, Andrew J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~